01 1SMS Pharmaceuticals
01 1SUMATRIPTAN SUCCINATE (ALTERNATIVE SYNTHESIS)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-07-02
Pay. Date : 2013-06-21
DMF Number : 20746
Submission : 2007-08-03
Status : Active
Type : II
20
Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUMATRIPTAN SUCCINATE (ALTERNATIVE SYNTHESIS), with a corresponding US DMF Number 20746.
Remarkably, this DMF maintains an Active status since its submission on August 03, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 02, 2013, and payment made on June 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
